Status:
COMPLETED
HPV Vaccination in Women With Cystic Fibrosis
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Human Papillomavirus Infection
Eligibility:
FEMALE
11-18 years
Brief Summary
The main risk factor for the development of cervical lesions is human papillomavirus (HPV) infection. Vaccination against human papillomavirus, which is offered to all girls aged 11 to 14, and catchin...
Eligibility Criteria
Inclusion
- girls with Cystic Fibrosis
- followed in a pediatric or mixed Cystic Fibrosis center of the region Auvergne Rhône Alpes (AuRA)
- aged 11 years or older
Exclusion
- \- Refusal to respond to the questionnaire
Key Trial Info
Start Date :
September 25 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2017
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT03265743
Start Date
September 25 2017
End Date
December 15 2017
Last Update
February 19 2018
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Nouvel Hôpital d'Estaing CRCM Mixte
Clermont-Ferrand, France, 63003
2
CHU Grenoble
Grenoble, France, 38043
3
Cystic Fibrosis Reference Center, Hospices Civils de Lyon
Pierre-Bénite, France, 69495